DK1173764T3 - Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12 - Google Patents

Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12

Info

Publication number
DK1173764T3
DK1173764T3 DK00922683T DK00922683T DK1173764T3 DK 1173764 T3 DK1173764 T3 DK 1173764T3 DK 00922683 T DK00922683 T DK 00922683T DK 00922683 T DK00922683 T DK 00922683T DK 1173764 T3 DK1173764 T3 DK 1173764T3
Authority
DK
Denmark
Prior art keywords
individual
concentration
pepsinogen
pgi
analyte
Prior art date
Application number
DK00922683T
Other languages
Danish (da)
English (en)
Inventor
Pentti Sipponen
Matti Haerkoenen
Osmo Suovaniemi
Erik Forsblom
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Application granted granted Critical
Publication of DK1173764T3 publication Critical patent/DK1173764T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
DK00922683T 1999-04-30 2000-04-28 Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12 DK1173764T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI990991A FI990991A (fi) 1999-04-30 1999-04-30 Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi

Publications (1)

Publication Number Publication Date
DK1173764T3 true DK1173764T3 (da) 2006-05-08

Family

ID=8554566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00922683T DK1173764T3 (da) 1999-04-30 2000-04-28 Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12

Country Status (12)

Country Link
EP (1) EP1173764B1 (ru)
JP (1) JP2002543430A (ru)
CN (1) CN1353816A (ru)
AT (1) ATE319088T1 (ru)
AU (1) AU4299700A (ru)
DE (1) DE60026285T2 (ru)
DK (1) DK1173764T3 (ru)
ES (1) ES2258453T3 (ru)
FI (1) FI990991A (ru)
PT (1) PT1173764E (ru)
RU (1) RU2224258C2 (ru)
WO (1) WO2000067029A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
FI20065542A0 (fi) * 2006-09-01 2006-09-01 Biohit Oyj Menetelmä ja näytteenottopakkaus vatsan limakalvon tilan arvioimiseksi

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi

Also Published As

Publication number Publication date
ATE319088T1 (de) 2006-03-15
WO2000067029A1 (en) 2000-11-09
DE60026285T2 (de) 2006-11-09
PT1173764E (pt) 2006-06-30
DE60026285D1 (de) 2006-04-27
RU2224258C2 (ru) 2004-02-20
AU4299700A (en) 2000-11-17
ES2258453T3 (es) 2006-09-01
FI990991A (fi) 2000-10-31
CN1353816A (zh) 2002-06-12
JP2002543430A (ja) 2002-12-17
FI990991A0 (fi) 1999-04-30
EP1173764B1 (en) 2006-03-01
EP1173764A1 (en) 2002-01-23

Similar Documents

Publication Publication Date Title
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
ES2316597T8 (es) Instrumentos analíticos, biosensores y métodos
DK1098658T3 (da) Manipulerede proteiner til detektering af analytter
ATE378404T1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
WO2003056314A3 (de) Analysensystem zur bestimmung einer analytkonzentration unter berücksichtigung von proben- und analytunabhängigen lichtintensitätsänderungen
DK0539477T3 (da) Fremgangsmåde til forstærkning af emissionssignalet af en luminescerende forbindelse
ATE329260T1 (de) Verfahren zur detektion von vitamin d metaboliten
DK2126586T3 (da) Direkte bestemmelse af vitamin D i serum eller plasma
ATE232559T1 (de) Verfahren zur signalverstärkung
MXPA05008143A (es) Eventos de alfalfa tolerantes a glifosato y metodos para su deteccion.
HK1079571A1 (en) Methods for direct detection of individual methotrexate metabolites
ATE545460T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
FI990992A (fi) Menetelmä peptisen haavan riskin määrittämiseksi
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DK1410014T4 (da) Fremgangsmåde til identifikation af prøver fra et pattedyr samt kit til udøvelse af fremgangsmåden
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
TW200508605A (en) Analysis method
DK1104547T3 (da) In vitro-fremgangsmåde til påvisning og diagnosticering af akutte koronarsyndromer
DK1173764T3 (da) Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12
BR0308506A (pt) Método para analisar concentrações de moléculas de coenzima a nas amostras biológicas
DK1386160T3 (da) Fremgangsmåde til påvisning af blodcelle-antigener og antistoffer rettet mod disse
FI20021598A0 (fi) Menetelmä happoon liittyvän sairausriskin detektoimiseksi yksilössä
WO2002077285A3 (en) Methods of determining the presence of polynucleotides employing amplification
RU2001132334A (ru) Способ идентификации индивидуума, у которого существует риск необратимых неврологических повреждений, включающий в себя этапы количественного определения концентрации пепсиногена i (pgi) и витамина в12
DK1299559T3 (da) Fremgangsmåde til identificering af inhibitorer for det anafase-promoverende kompleks